Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Tetanus × sargramostim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 16 Lymphoma 10 Leukemia, Myeloid, Acute 9 Breast Neoplasms 9 Neuroblastoma 8 Myelodysplastic Syndromes 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Ovarian Neoplasms 7 Lymphoma, Follicular 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Multiple Myeloma 6 Melanoma 6 Prostatic Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 4 Glioblastoma 4 Fallopian Tube Neoplasms 4 Osteosarcoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Mantle-Cell 3 Ganglioneuroblastoma 3 Colorectal Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Neoplasms 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lung Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Hodgkin Disease 2 Gliosarcoma 2

Interventions

sargramostim 1 Vaccines 1 Temozolomide 1 Papillomavirus Vaccines 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡